Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.8.0.1
Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 12 Months Ended
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Segment
Dec. 31, 2016
USD ($)
Cash equivalents  
Impairment charge   1,038,285
Derivative liability $ 56,000,000 2,803  
Interest expenses 41,000,000 8,649,232
Offset to additional paid in capital   16,000,000  
Deemed dividend $ 51,000,000 53,300,000  
Total loss realized on instruments   12,400,000 7,000,000
Unrecognized tax benefits  
Number of operating segment | Segment   2  
Derivative Liabilities [Member]      
Embedded conversion of derivative liabilities   $ 1,600,000  
Debt conversion percentage   85.00%  
Derivative Liabilities One [Member]      
Debt conversion percentage   85.00%  
Fair value of warrants   $ 10,500,000  
Derivative Liabilities Two [Member]      
Fair value of warrants   300,000  
Genomas Acquisition [Member]      
Goodwill impairment charge   $ 1,000,000